In an effort to promote the reporting of clinical trial data and
amplify the search for COVID-19 therapies, the Centers for Medicare
& Medicaid Services (CMS) announced on April 20 that clinicians
who participate in its Quality Payment Program (QPP) can now earn
credit in the Merit-Based Incentive Payment System (MIPS) for
participation in a clinical trial and reporting of the clinical
information.
To receive credit for this new MIPS "COVID-19 Clinical
Trials" improvement activity (IA_ERP_3), MIPS-eligible
clinicians must attest to participation in a COVID-19 clinical
trial utilizing a drug or biological product to treat a patient
with a COVID-19 infection, and must report their findings through a
clinical data repository or clinical data registry.
